Djura Piersma
Medisch Spectrum Twente(NL)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma(2022)495 cited
- → Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial(2020)489 cited
- → Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry(2020)177 cited
- → Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome(2009)126 cited
- → Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease(2021)104 cited
- → Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands(2016)104 cited
- → Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma(2022)100 cited
- → A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients(2006)60 cited
- → Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study(2022)56 cited
- → LH receptor gene mutations and polymorphisms: An overview(2006)54 cited